Journal of Turkish Clinical Biochemistry

The official publication of Turkish Society of Clinical Biochemistry

Diamond OA
No APCs
First Decision
30 Days
Indexed In
TR Dizin
Original Research
April 01, 2015
JTCB. 2015 Apr 1; 13 (1) : 029-034
72 159
PDF

Beta Thalassemia Trait Accompanying Iron Deficiency Anemia

1 İzmir Katip Çelebi Üniversitesi, Atatürk Eğitim ve Araştırma Hastanesi, Tıbbi Biyokimya Bölümü, İzmir, Türkiye

Abstract

Objective: Anemia is a commonly encountered health problem. In this study, togetherness of beta thalassemia trait with iron deficiency anemia was investigated using by some biochemical and hematological cell count indices.

Material and Methods: The 128 specimens of whole blood samples (n = 895) that were sent to our laboratory were selected as beta thalassemia carriers by hematological indices and HbA2 values. The hemoglobin chain analysis was performed by high performance liquid chromatography method. Complete blood count, serum iron, total iron binding capacity, serum ferritin level, Mentzer Index and transferrin saturation index were retrospectively evaluated.

Results: In all carriers included in the review, 63 % were females, 23 % were men and 14 % were children under the age of 16. Although low ferritin levels were observed in only one carrier of each men and children group, in female carriers this was found as 28 %. Mentzer Index was found higher than 13 in 20 % of female, 3 % of men and 6 % of children carriers. Transferrin saturation index was found lower than 10 % in 14 % of female, 10 % of men and 11 % of children carriers groups.

Conclusion: Especially in female and child beta thalassemia carriers, it should be taken into account the possible togetherness with the iron deficiency during the treatment period,.

Citation

Ünal, Hülya, Ayşenur Atay, Erkan Söğüt, Leyla Demir, Saliha Aksun, and Recep Sütçü. 2015. “Beta Thalassemia Trait Accompanying Iron Deficiency Anemia”. Journal of Turkish Clinical Biochemistry 13 (1):029-034. https://turkclinbiochem.org/index.php/pub/article/view/217.

Publish with JTCB

Diamond Open Access

Fully Diamond OA with no APCs and no submission fees. Your research is freely available to readers worldwide from the day it publishes.

30-Day First Decision

Double-blind peer review from an active editorial team returns a first decision in about 30 days, keeping your manuscript moving.

Global Platform

Backed by the Turkish Society of Clinical Biochemistry, JTCB welcomes submissions from researchers worldwide and reaches an international laboratory audience.

Focused Laboratory Scope

Method validation, analyzer comparisons, reference intervals, quality indicators, preanalytical studies, and instructive clinical case reports.

Credible and Discoverable

All manuscripts publish in English and follow ICMJE and COPE guidelines, with Crossref DOIs and TR Dizin indexing ensuring global discoverability.